<

SANOFI-AVENTIS (EPA:SAN) Press Release: FDA approves Dupixent® (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis

Transparency directive : regulatory news

20/05/2022 21:15



Other stories

24/04/2024 17:26
24/04/2024 18:01
24/04/2024 17:06
24/04/2024 14:34
24/04/2024 12:41
24/04/2024 16:32
24/04/2024 14:30
24/04/2024 08:49
24/04/2024 12:28
24/04/2024 09:13
24/04/2024 17:22
24/04/2024 14:00
24/04/2024 11:51
24/04/2024 09:28
24/04/2024 17:44
24/04/2024 12:52
24/04/2024 16:23
24/04/2024 16:19
24/04/2024 10:00
22/04/2024 21:47
23/04/2024 17:30
24/04/2024 09:00
24/04/2024 12:26
24/04/2024 15:00
24/04/2024 12:09
24/04/2024 12:11
24/04/2024 12:58
24/04/2024 14:08
24/04/2024 10:02
24/04/2024 14:38
24/04/2024 08:05
24/04/2024 01:01
23/04/2024 18:34
24/04/2024 17:00
24/04/2024 14:25
24/04/2024 13:29
24/04/2024 09:15
24/04/2024 11:25